Concepedia

Bhalchandra Mirlekar

BM

8

Publications

1K

Citations

8

H-Index

2015

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

University of Pittsburgh

Bhalchandra Mirlekar is an author at University of North Carolina at Chapel Hill specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2015–2022

8

Publications

8

Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells

Hongwei Du, Koichi Hirabayashi, Sarah Ahn et al. · Cancer Cell · 2019 · 477 citations

, , +7

STING-induced regulatory B cells compromise NK function in cancer immunity

Sirui Li, Bhalchandra Mirlekar, Brandon M. Johnson et al. · Nature · 2022 · 282 citations · Full text

, , +6

B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer

Bhalchandra Mirlekar, Daniel Michaud, Samuel Lee et al. · Cancer Immunology Research · 2020 · 104 citations · Full text

Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity

Bhalchandra Mirlekar, Yan Wang, Sirui Li et al. · Cell Reports Medicine · 2022 · 62 citations · Full text

, , +17

IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer

Bhalchandra Mirlekar, Daniel Michaud, Ryan Searcy et al. · Cancer Immunology Research · 2018 · 59 citations · Full text

Rows per page

1–5 of 8